TPSF
MYGN icon

Texas Permanent School Fund’s Myriad Genetics MYGN Stock Holding History

Texas Permanent School Fund’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-77,485
Closed -$1.65M – 904
2024
Q1 		$1.65M Buy
77,485
+889
+1% +$19.1K 0.01% 1148
2023
Q4 		$1.47M Buy
76,596
+7,054
+10% +$122K 0.01% 1171
2023
Q3 		$1.12M Sell
69,542
-2,266
-3% -$43.1K 0.01% 1206
2023
Q2 		$1.66M Sell
71,808
-863
-1% -$18.8K 0.02% 1071
2023
Q1 		$1.69M Buy
72,671
+18,193
+33% +$369K 0.02% 1041
2022
Q4 		$790K Sell
54,478
-3,515
-6% -$65.5K 0.01% 1210
2022
Q3 		$1.11M Sell
57,993
-77
-0.1% -$1.77K 0.02% 1050
2022
Q2 		$1.05M Buy
58,070
+1,457
+3% +$30.3K 0.02% 1103
2022
Q1 		$1.43M Sell
56,613
-964
-2% -$24.7K 0.02% 1017
2021
Q4 		$1.59M Sell
57,577
-163
-0.3% -$4.72K 0.02% 1021
2021
Q3 		$1.86M Buy
57,740
+319
+0.6% +$10.6K 0.02% 929
2021
Q2 		$1.76M Buy
57,421
+1,232
+2% +$35.6K 0.02% 995
2021
Q1 		$1.71M Sell
56,189
-4,201
-7% -$119K 0.02% 993
2020
Q4 		$1.19M Sell
60,390
-9,403
-13% -$152K 0.02% 1093
2020
Q3 		$910K Buy
69,793
+10,888
+18% +$138K 0.01% 1150
2020
Q2 		$668K Sell
58,905
-4,438
-7% -$63K 0.01% 1198
2020
Q1 		$906K Buy
63,343
+12,460
+24% +$263K 0.02% 1007
2019
Q4 		$1.39M Buy
50,883
+607
+1% +$16.7K 0.02% 937
2019
Q3 		$1.44M Buy
50,276
+480
+1% +$14K 0.02% 892
2019
Q2 		$1.38M Buy
49,796
+45
+0.1% +$1.27K 0.02% 919
2019
Q1 		$1.65M Buy
49,751
+828
+2% +$25.2K 0.03% 815
2018
Q4 		$1.42M Buy
48,923
+4,300
+10% +$155K 0.03% 834
2018
Q3 		$2.05M Sell
44,623
-496
-1% -$22.1K 0.03% 750
2018
Q2 		$1.69M Sell
45,119
-1,123
-2% -$37.9K 0.02% 864
2018
Q1 		$1.37M Sell
46,242
-562
-1% -$19K 0.02% 938
2017
Q4 		$1.61M Sell
46,804
-3,159
-6% -$107K 0.02% 900
2017
Q3 		$1.81M Buy
49,963
+230
+0.5% +$6.56K 0.02% 849
2017
Q2 		$1.28M Buy
49,733
+6,134
+14% +$130K 0.02% 994
2017
Q1 		$837K Buy
+43,599
New +$773K 0.01% 1155

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Texas Permanent School Fund's MYGN Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Myriad Genetics (MYGN) in Q2 2024, closing a stake of 77,485 shares — an estimated $1.65M sold.

Texas Permanent School Fund first reported a position in MYGN in Q1 2017 and held it in 29 quarters. The position peaked at $2.05M in Q3 2018. 223 funds tracked by Wall St. Rank hold MYGN as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Myriad Genetics position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 77,485 Myriad Genetics shares in Q2 2024, an estimated $1.65M.
  • Texas Permanent School Fund first reported a position in Myriad Genetics in Q1 2017 and held it in 29 quarters.
  • Texas Permanent School Fund's Myriad Genetics position peaked at $2.05M in Q3 2018.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.